Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2007
05/24/2007WO2007057402A1 Emp4 gene
05/24/2007WO2007057212A1 High activity growth factor mutants
05/24/2007WO2007057207A1 Production of recombinant collagen like proteins
05/24/2007WO2007057062A1 Human bocavirus and methods of diagnosis and treatment
05/24/2007WO2007057018A2 Glucoamylase variants
05/24/2007WO2007056907A1 TRUNCATED GLUCAGON-LIKE PEPTIDE-1 (sGLP-1) AND ITS PREPARING METHOD AND USE
05/24/2007WO2007056867A1 Modified pore-forming protein toxins and use thereof
05/24/2007WO2007056858A1 Anti-alpha2 integrin antibodies and their uses
05/24/2007WO2007056848A1 Use of bacteriocins for promoting plant growth and disease resistance
05/24/2007WO2007056812A1 A molecule and chimeric molecules thereof
05/24/2007WO2007039699A3 Proteinaceous substrate for the detection of calpain-3 activity
05/24/2007WO2007037503A9 An l-amino acid-producing bacterium and a method for producing an l-amino acid
05/24/2007WO2007031280A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
05/24/2007WO2007028574A3 Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules
05/24/2007WO2007028259A3 Antigens for vaccination against and detection of mycoplasma suis
05/24/2007WO2007027777A3 Nucleotide sequences encoding insecticidal proteins
05/24/2007WO2007023316A3 Assay for trypanosome infection
05/24/2007WO2007017907A3 A novel nucleic acid encoding a novel protein of candida albicans and uses thereof
05/24/2007WO2007014743A3 Cd33-specific single-chain immunotoxin and method of use
05/24/2007WO2007014199A3 Tfpi fragments as anti-microbial agents
05/24/2007WO2007000332A3 Biosynthetic process for the preparation of gallidermin
05/24/2007WO2006135912A3 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
05/24/2007WO2006122327A8 Milk fat globule epidermal growth factor-factor viii and sepsis
05/24/2007WO2006098998A3 Methods and compositions for modulating vascular integrity
05/24/2007WO2006096816A3 Human leptin-derived polypeptides and uses thereof
05/24/2007WO2006095347A3 VOLTAGE DEPENDENT ANION CHANNEL (VDACl) COMPOSITIONS AND METHODS OF USE THEREOF FOR REGULATING APOPTOSIS
05/24/2007WO2006087550A3 Amyloid-binding peptides, analogues and uses thereof
05/24/2007WO2005123959A3 Multiplexing assays for analyte detection
05/24/2007WO2005107383A8 Secreted insecticidal protein and gene compositions from bacillus thuringiensis and uses therefor
05/24/2007WO2005107357A3 Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes
05/24/2007WO2005097205A8 Dna virus microrna and methods for inhibiting same
05/24/2007WO2005082008A3 Methods for diagnosing and treating bladder cancer
05/24/2007WO2005049640A3 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
05/24/2007WO2005016952A3 Polyvalent immunogen
05/24/2007WO2000009653A3 Method of inhibiting cathepsin k
05/24/2007US20070118931 Plants having modified growth characteristics and method for making the same
05/24/2007US20070118925 Plastid Transit Peptides
05/24/2007US20070118924 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
05/24/2007US20070118923 regulating gene expression in plants
05/24/2007US20070118922 Novel plant promoter
05/24/2007US20070118913 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases
05/24/2007US20070117970 generating an immune response, comprising administering to a mammal variable major protein (VMP)-like polypeptides as antigens for immunoprophylaxis, immunotherapy and immunodiagnosis; antibodies; Lyme disease
05/24/2007US20070117969 PTH receptor and screening assay utilizing the same
05/24/2007US20070117968 Metal binding proteins and associated methods
05/24/2007US20070117967 Homogeneous preparations of il-28 and il-29
05/24/2007US20070117966 Treating or preventing an alpha nu beta 3 integrin mediated disease or disorder; , imaging tissues using positron emission tomography or magnetic resonance imaging, assessing the metastatic characteristics of a tumor, and delivering DNA to a cell
05/24/2007US20070117965 Streptococcal polypeptide specific immunoglobulin for use in diagnosis, prevention and treatment of microoganismal infection; genetic vaccines
05/24/2007US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester
05/24/2007US20070117757 Polypeptide copolymer for use in treatment of multiple sclerosis; glatiramer acetate; copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons; chromatographic separation; cleaving by acid hydrolysis or enzymetic hydrolysis; isolation by dialysis or ultrafiltration,
05/24/2007US20070117756 FVII or FVIIa Gla domain variants
05/24/2007US20070117755 Gene fusion between soluble receptor with a ligand binding domain and a trimerization tag from the C-propeptide domain of pro-collagen, which iscapable of self-assembly into a covalently linked trimer; more potent blocker than dimeric TNF receptor decoys in inhibiting TNF- alpha inflammatory disease
05/24/2007US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof
05/24/2007US20070117751 Compositions and methods for diagnosing and treating cancer
05/24/2007US20070117749 Production of mersacidin and its variants in SigH and/or mrsA negative bacillus host cells
05/24/2007US20070117748 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
05/24/2007US20070117747 Treating disorders of the nervous system
05/24/2007US20070117746 Treatment of viral infections
05/24/2007US20070117745 Cardio myopeptidin, the production and the use thereof
05/24/2007US20070117742 producing a fraction enriched in a proteinaceous molecule having N-linked glycans comprising sialyl-Lewis X, Lewis X or LacdiNac structures; cerebral ischemia or myocardial infarction; composition comprising erythropoietin molecules
05/24/2007US20070117741 An isolated polypeptide comprising SEQ. ID. NO. 1 and an excipient as a defensin-stumulating composition; fusion proteins; microbiocides; fungicides; mouth wash; toothpaste; films; cornea; eyedrops or -cream; skin creams and lotions;side effect reduction
05/24/2007US20070117197 Lactobacilli expressing biologically active polypeptides and uses thereof
05/24/2007US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
05/24/2007US20070117187 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
05/24/2007US20070117186 Highly efficient secretory signal peptide and a protein expression system using the peptide thereof
05/24/2007US20070117184 In vivo incorporation of unnatural amino acids
05/24/2007US20070117183 Corynebacterium glutamicum genes encoding metabolic pathway proteins
05/24/2007US20070117182 Nucleic acids conferring transcriptional responsiveness on the RANKL gene promoter and uses thereof
05/24/2007US20070117180 Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme
05/24/2007US20070117176 Process for the extraction of atelopeptide collagen from a collagenous source by microbial treatment
05/24/2007US20070117169 Using fluorescence-labeled glucan binding domain protein in the diagnosis of mycosis; detecting a trace amount of a fungal component
05/24/2007US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes
05/24/2007US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/24/2007US20070117162 Kidney-specific urate transporter and gene thereof
05/24/2007US20070117161 Antibody Specific for Human 4-1BB Receptor
05/24/2007US20070117159 Isolated polypeptide comprising a claimed amino acid sequence
05/24/2007US20070117157 Parathyroid hormone-like polypeptides
05/24/2007US20070117156 Method of detecting native proBNP
05/24/2007US20070117155 Drug screening for agonists and antagonists of the mammalian histamine receptor; for inflammation, asthma, and allergy, atopic dermatitis, stroke, myocardial infection, migraine, COPD, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and psoriasis
05/24/2007US20070117153 Molecular conjugate
05/24/2007US20070117150 Carbon nanotube binding peptides
05/24/2007US20070117149 Carbon nanotube binding peptides
05/24/2007US20070117147 Carbon nanotube binding peptides
05/24/2007US20070117146 Allelic variants of GPR50
05/24/2007US20070117145 Interferon-alpha induced genes
05/24/2007US20070117141 Identification and cloning of a full-length human clnk-related gene, MIST (mast cell immunoreceptor signal transducer)
05/24/2007US20070117138 Splice variant cannabinoid receptor (cb1b)
05/24/2007US20070117130 Novel activin receptor and uses thereof
05/24/2007US20070117129 Antigen arrays for treatment of bone disease
05/24/2007US20070117124 Achaete-Scute Like-2 Polypeptides and Encoding Nucleic Acids and Methods for the Diagnosis and Treatment of Tumor
05/24/2007US20070117122 Methods of diagnosing or prognosticating age-related macular degeneration
05/24/2007US20070117113 Use of DNA to produce compounds exhibiting antibiotic activity based on the anthramycin structures
05/24/2007US20070117098 'signalin' family of TGFbeta signal transduction proteins and uses related thereto
05/24/2007US20070117097 Novel proteins and novel genes encoding the same
05/24/2007US20070117088 Methods and kits for detection of prion diseases
05/24/2007US20070116726 Immunisation against Chlamydia pneumoniae
05/24/2007US20070116721 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
05/24/2007US20070116718 Fusion proteins comprising bacteriophage coat protein and asingle-chain T cell receptor
05/24/2007US20070116716 Sars coronavirus s proteins and uses thereof
05/24/2007US20070116715 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection
05/24/2007US20070116712 Novel streptococcus antigens